Literature DB >> 26767052

Network analysis in the identification of special mechanisms between small cell lung cancer and non-small cell lung cancer.

Weisan Zhang1, Qiang Zhang1, Mingpeng Zhang1, Yun Zhang1, Fengtan Li2, Ping Lei1.   

Abstract

BACKGROUND: To explore the similar and different pathogenesis between non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
METHODS: This study used bioinformatics methods, including functional enrichment analysis, compared the topological features of SCLC and NSCLC in the human protein interaction network in a system aspect, and analyzed the highly intense modules from an integrated network.
RESULTS: This study included 5082 and 2781 significantly different expression genes for NSCLC and SCLC, respectively. The differently expressed genes of NSCLC are mainly distributed in the extracellular region and synapse. By contrast, the genes of SCLC are located in the organelle, macromolecular complex, membrane-enclosed lumen, cell part, envelope, and synapse. Compared with SCLC, the differently expressed genes of NSCLC act in the biological regulation, multicellular organismal process, and viral reproduction and locomotion, which show that NSCLC is more likely to cause a wide range of cancer cell proliferation and virus infection than SCLC. The network topological properties of SCLC and NSCLC are similar, except the average shortest path length, which indicates that most of the genes of the two lung cancers play a similar function in the entire body. The commonly expressed genes show that all of the genes in the module may also cause NSCLC and SCLC, simultaneously.
CONCLUSIONS: The proteins in module will involve the same or similar biological functions and the interactions among them induce the occurrence of lung cancer. Moreover, a potential biomarker of SCLC is the interaction between APIP and apoptotic protease activating factor (APAF)1, which share a common module.

Entities:  

Keywords:  Bioinformatics; lung cancer; pathology

Year:  2014        PMID: 26767052      PMCID: PMC4704339          DOI: 10.1111/1759-7714.12134

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  26 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

2.  Discovering disease-genes by topological features in human protein-protein interaction network.

Authors:  Jianzhen Xu; Yongjin Li
Journal:  Bioinformatics       Date:  2006-09-05       Impact factor: 6.937

3.  Non-small-cell lung cancer: then and now.

Authors:  Joan H Schiller; David R Gandara; Glenwood D Goss; Everett E Vokes
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

4.  Mu1B, a novel adaptor medium chain expressed in polarized epithelial cells.

Authors:  H Ohno; T Tomemori; F Nakatsu; Y Okazaki; R C Aguilar; H Foelsch; I Mellman; T Saito; T Shirasawa; J S Bonifacino
Journal:  FEBS Lett       Date:  1999-04-23       Impact factor: 4.124

5.  Identification and characterization of novel clathrin adaptor-related proteins.

Authors:  H Takatsu; M Sakurai; H W Shin; K Murakami; K Nakayama
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

6.  Analysing protein-protein interaction networks of human liver cancer cell lines with diverse metastasis potential.

Authors:  Hai-Jun Zhou; Yin-Kun Liu; Zhuozhe Li; Dong Yun; Qiang-Ling Shun; Kun Guo
Journal:  J Cancer Res Clin Oncol       Date:  2007-04-26       Impact factor: 4.553

7.  Novel QTLs for HDL levels identified in mice by controlling for Apoa2 allelic effects: confirmation of a chromosome 6 locus in a congenic strain.

Authors:  Carrie L Welch; Sara Bretschger; Ping-Zi Wen; Margarete Mehrabian; Nashat Latib; Jamila Fruchart-Najib; Jean Charles Fruchart; Christy Myrick; Aldons J Lusis
Journal:  Physiol Genomics       Date:  2004-03-12       Impact factor: 3.107

Review 8.  Human epithelial cell immortalization as a step in carcinogenesis.

Authors:  Martha R Stampfer; Paul Yaswen
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

9.  Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord.

Authors:  Alexandre Montpetit; Stéphanie Côté; Edna Brustein; Christian A Drouin; Line Lapointe; Michèle Boudreau; Caroline Meloche; Régen Drouin; Thomas J Hudson; Pierre Drapeau; Patrick Cossette
Journal:  PLoS Genet       Date:  2008-12-05       Impact factor: 5.917

10.  Functional identification of APIP as human mtnB, a key enzyme in the methionine salvage pathway.

Authors:  Camille Mary; Paula Duek; Lisa Salleron; Petra Tienz; Dirk Bumann; Amos Bairoch; Lydie Lane
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  4 in total

Review 1.  DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.

Authors:  Altan Kara; Aykut Özgür; Sinem Nalbantoğlu; Abdullah Karadağ
Journal:  Mol Biol Rep       Date:  2021-04-15       Impact factor: 2.316

2.  A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification.

Authors:  Xin-Ping Xie; Yu-Feng Xie; Hong-Qiang Wang
Journal:  BMC Bioinformatics       Date:  2017-08-23       Impact factor: 3.169

3.  Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model.

Authors:  Zhirui Fan; Wenhua Xue; Lifeng Li; Chaoqi Zhang; Jingli Lu; Yunkai Zhai; Zhenhe Suo; Jie Zhao
Journal:  J Transl Med       Date:  2018-07-20       Impact factor: 5.531

4.  Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target.

Authors:  Xiao Xu Li; Jiayi Yin; Jing Tang; Yinghong Li; Qingxia Yang; Ziyu Xiao; Runyuan Zhang; Yunxia Wang; Jiajun Hong; Lin Tao; Weiwei Xue; Feng Zhu
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.